This correction factor is intended to ensure that the R&D efforts are carried out by the taxpayer or by independent contractors on behalf of the taxpayer. It is appropriate to penalize acquisition costs and R&D expenditure outsourced within a company-related entity. These “non-qualifying” costs, introduced in the nexus ratio, weigh on the balance to reduce the tax benefit. In contrast, “qualifying” expenses are internal R&D costs or those subcontracted to a non-related company. Among other subtleties, such as a 30% uplift, it should be noted that the nexus ratio is a rebuttable presumption: this means that its application can be challenged when the deduction is too low.

Share This Post

IP Box Barometer 2022

The first European IP Box barometer, this document informs you about the reasons for its success in Europe and the sectors concerned.

Related articles

Securing your IID

The IID is a deduction, the burden of proof lies with the taxpayer. Therefore, the importance of a comprehensive scientific and tax report is obvious…

Read more

Calculating your IID

For several years, the patent income deduction (PID) was the dominant tax incentive for innovation. Since 1 July 2016, this measure has been gradually replaced

Read more